Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -7.00p -1.17% 589.00p 590.00p 590.00p 598.00p 588.00p 596.00p 77,643 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -1.8 -5.1 - 223.07

International Biotechnology Share Discussion Threads

Showing 326 to 349 of 475 messages
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
09/4/2014
14:08
Westhouse's data do reveal further weakness in the NAV since the last actual NAV release by IBT. This has been led by the fund's positions in Gilead Sciences (GILD US) and Biogen Idec (BIIB US). Yet this softness in the NAV is now arguably more than reflected in IBT's discount pricing relative to its peers. It was another rollercoaster day for the biotech stocks yesterday (both funds and underlying stocks), with key stocks partly recovering from initial falls. International Biotechnology Trust (IBT.L, discount -24.2%, Buy) is shortly due to announce its interim results to the end of February and, given the value that has opened up on this fund, the views of the manager with regard to recent events and forward expectations will be particularly interesting when we meet at an analyst meeting planned for 22 April.
davebowler
09/4/2014
12:03
Confirmed it is and looks to have bottomed for now
tokyo sexwhale
09/4/2014
10:58
Suspect the NAV will be broadly the same as yesterday as NBI index was again flat last night.
rogerrail
09/4/2014
09:37
Expect this to rise sharply today once NAV announced not too late to top up prior
tokyo sexwhale
08/4/2014
13:59
After being 10% down earlier today BIOG has turned around is is back to near the opening price. Let's hope IBT can follow suit.
snowydays
08/4/2014
12:18
me too , now 24% discount!
rogerrail
08/4/2014
11:57
Nav slightly up on yesterday agree way oversold now have added this morning
tokyo sexwhale
08/4/2014
10:49
Quite a discount; hold quite a lot of these plus BIOG and Tech IT's - most down 25% in a month so my strategy of these investments providing long term growth to sit along boring high income stocks is being put to the test.
philo124
08/4/2014
10:03
way oversold now, NBI index was up 0.5% last night and most of IBT top 10 holdings either up or flat , only 9th largest holding Mylan down singficantly -4.4%, seems to be tracking BIOG not the NBI index, pity it was not tracking it on the way up ! %NBI 2,367.94 +11.34 0.48% 1.BIIB 294.19 +5.92 2.05% 2.GILD 72.23 +0.030 3.REGN 287.19 +1.85 0.65% 4.CELG 139.16 +1.78 1.30% 5.ALXN 145.66 +3.16 2.22% 6.AMGN 118.82 -0.290 -0.24% 7.ILMN 140.46 +1.89 1.36% 8.VRTX 66.40 +0.560 0.85% 9.MYL 48.40 -2.23 -4.40% 10 APTIV n/a IBT 256.50 -14.00 -5.18% BIOG 429.88 -18.62 -4.15
rogerrail
07/4/2014
17:09
not all of them - maybe take a look at PEBI ! m
maurillac
07/4/2014
16:18
Techs and Bios out of favour at the moment.
philo124
07/4/2014
16:15
Discount to NAV now widened to over 18%, this has to be an opportunity to add.
rogerrail
28/3/2014
12:32
NAV is still higher than the peak price in FEB; Date NAV Pence Wednesday 26 Mar Ex Income 349.36
davebowler
26/3/2014
14:00
general weakness in the sector will keep the wide discount for a while yet imo.
pyemckay
26/3/2014
13:52
Dave - Premium/discount has gone from about -5% in early Nov to about -25% now. http://markets.ft.com/research/Markets/Tearsheets/Performance?s=IBT:LSE
trader2
26/3/2014
11:36
Net Asset Values The Board of International Biotechnology Trust plc announces that the unaudited net asset value per share Date NAV Pence Tuesday 25 Mar Ex Income 355.66
davebowler
26/3/2014
11:15
As I type ^NBI off 12% from recent high - IBT off 14%
trader2
26/3/2014
10:48
I think you'll find that falls track back to the row about pricing of Gilead's new hepatitis C drug and whether biotechs can make such prices (USD84000 per patient) stick or whether insurers and govts will decline to buy. Lots of biotech business models are predicated on such high prices....... See http://www.fiercepharma.com/story/politicians-add-fuel-firestorm-over-gileads-hep-c-drug-pricing/2014-03-24
vulgaris
26/3/2014
09:51
Sure getting a good shake!
trader2
24/3/2014
16:49
Yes, the NASDAQ biotech index is falling like a stone. Fears the bubble is bursting. http://uk.finance.yahoo.com/q?s=^NBI
snowydays
24/3/2014
16:44
anyone know why this has dropped so much today?
incar
24/3/2014
13:31
NAV 366 today
tokyo sexwhale
24/3/2014
00:13
Discount has widened since 5th then. NAV 389p share price 330p Now NAV 379p share price 315p
melody9999
06/3/2014
13:20
Date NAV Pence ------------------ ------------ ------- Wednesday 05 Mar Ex Income 389.76
davebowler
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180523 03:09:04